What escitalopram (Lexapro) dose is equivalent to fluoxetine (Prozac) 10 mg in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Escitalopram 10 mg is the equivalent dose to fluoxetine (Prozac) 10 mg

Based on the most rigorous dose-equivalence methodology using randomized controlled trial data, fluoxetine 40 mg/day is equivalent to escitalopram 18 mg/day 1. Using this ratio, fluoxetine 10 mg corresponds to approximately escitalopram 4.5 mg, though in clinical practice you would round to the nearest available dose of 5 mg escitalopram.

However, the standard therapeutic starting dose of escitalopram is 10 mg/day 2, 1, which is also the FDA-approved starting dose for adolescents aged 12 years and older 2. This 10 mg dose represents the most commonly prescribed and studied dose in clinical trials 3.

Practical Dosing Algorithm

For a direct switch from fluoxetine 10 mg:

  • Start escitalopram at 10 mg once daily 2, 1—this is the standard therapeutic dose and requires no washout period since neither drug is an MAOI 4
  • The 10 mg escitalopram dose will provide slightly greater serotonergic activity than fluoxetine 10 mg based on dose-equivalence ratios, but this difference is clinically insignificant and well-tolerated 1, 3
  • Assess response at 6–8 weeks before considering dose adjustment 4

If the patient is highly sensitive to medication or elderly:

  • Consider starting at 5 mg escitalopram daily for 1 week, then increase to 10 mg 2
  • Elderly patients do not require routine dose reduction based on pharmacokinetics alone, but lower starting doses may improve tolerability 5, 6

Key Pharmacokinetic Considerations

  • Escitalopram reaches steady-state in 7–10 days 5, compared to fluoxetine's 4–6 week steady-state due to its long half-life 4
  • No washout period is required when switching from fluoxetine to escitalopram 4
  • Escitalopram has minimal drug interactions due to negligible CYP enzyme inhibition 5, unlike fluoxetine which is a potent CYP2D6 inhibitor 4

Critical Safety Screening

Before initiating escitalopram, verify the patient:

  • Has not taken an MAOI within 14 days 4—concurrent use can precipitate serotonin syndrome within 24–48 hours
  • Is not taking other serotonergic agents (tramadol, meperidine, methadone, fentanyl, dextromethorphan, St. John's wort) 4
  • Does not have risk factors for QT prolongation 4—escitalopram can prolong QT at higher doses

Monitoring During Transition

  • Watch for serotonin syndrome signs in the first 1–2 weeks: confusion, agitation, tremor, clonus, hypertension, tachycardia, diaphoresis 4
  • Monitor for suicidal ideation, especially in patients younger than 24 years 2, 4—risk is highest in the first 1–2 months of any antidepressant therapy

Common Pitfall to Avoid

Do not underdose escitalopram at 5 mg thinking it is equivalent to fluoxetine 10 mg 1. While the mathematical ratio suggests 4.5 mg, the 10 mg dose is the evidence-based therapeutic starting dose that has demonstrated efficacy in clinical trials 2, 3. Starting at 5 mg may delay therapeutic response and is only appropriate for highly sensitive patients or as a brief titration step 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Research

Escitalopram in the treatment of depressed elderly patients.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.